MedPath

Cerebral Perfusion in Hypothermic Circulatory Arrest

Completed
Conditions
Cerebrovascular Circulation
Interventions
Diagnostic Test: Measurement of tissue oxygenation index (TOI)
Registration Number
NCT03484104
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Brief Summary

Selective antegrade cerebral perfusion (sACP) during aortic arch surgery in hypothermic circulatory arrest (HCA) is an established method for intraoperative neuroprotection. Although sACP is established as a beneficial method to reduce secondary neurological side effects due to brain-malperfusion, there are several parameters like sACP flow rate, perfusion pressure or temperature of the perfusate, where the optimal values remain unclear. The flow rate of the sACP-perfusate is increased according to center-specific standard-procedures. The optimal sACP flow rate, monitored by near infrared spectroscopy (NIRS), is to be investigated in this single center clinical prospective observational study. 40 Patients are enrolled over an estimated period of 14 months.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age 18 years or older
  • Elective cardiac surgery with cardiopulmonary bypass
  • Hypothermic circulatory arrest
  • General informed consent signed
Exclusion Criteria
  • Severe stenotis in cerebral arteries

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Hypothermic circulatory arrestMeasurement of tissue oxygenation index (TOI)Patients undergoing cardiac surgery with hypothermic circulatory arrest and selective antegrade cerebral perfusion
Primary Outcome Measures
NameTimeMethod
TOIthrough study completion, an average of 1 year

The primary outcome is the tissue oxygenation index (TOI: NIRS value) at sACP flow rates of 6 , 8 and 10 (ml/kg/min) in comparison to the TOI measured awake.

Secondary Outcome Measures
NameTimeMethod
Vmcathrough study completion, an average of 1 year

The secondary outcome is the mean blood flow velocity in the middle cerebral artery at sACP the specified flow rates in comparison to the VmMCA during general anesthesia, after anesthesia induction.

Neurologic accidentsthrough study completion, an average of 1 year

An additional secondary outcome measure are any neurologic accidents during the same hospital stay.

Trial Locations

Locations (2)

Inselspital, University Hospital Bern, University of Bern

🇨🇭

Bern, Switzerland

University of Bern

🇨🇭

Bern, Switzerland

© Copyright 2025. All Rights Reserved by MedPath